One of the most common and inexpensive screening tests, urine cytology, is largely ineffective and pathologically subjective, with limited sensitivity and specificity.
Kim, Ph. Founded in , KDx is focused on developing diagnostic and prognostic tests to improve early detection and therapy decisions in cancer. KDx can develop tests based on the same biomarker for other platforms and sample types and plans to expand its product line both by offering new formats of the bladder cancer test as well as tests for other cancers.
Additional information is available at www. Contact: Hillary Garcia Media Relations [email protected]. Sample Collection Instructions. Fact Sheet For Patients. Federal Government. Read our disclaimer for details. Before participating in a study, talk to your health care provider and learn about the risks and potential benefits.
Learn more. Try the modernized ClinicalTrials. Learn more about the modernization effort. Hide glossary Glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Search for terms. Explore , research studies in all 50 states and in countries. Find a study all fields optional Saved Studies. Recruiting and not yet recruiting studies All studies.
0コメント